Stéphanie Braillard (Stephanie Braillard)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Gold Nanoparticles

Toxoplasma Gondii

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Stéphanie Braillard, Martine Keenan, Karen J Breese, Jacob Heppell, Michael Abbott, Rafiqul Islam, David M Shackleford, Kasiram Katneni, Elly Crighton, Gong Chen, Rahul Patil, Given Lee, Karen L White, Sandra Carvalho, Richard J Wall, Giulia Chemi, Fabio Zuccotto, Silvia González, Maria Marco, Julianna Deakyne, David Standing, Gino Brunori, Jonathan J Lyon, Pablo Castañeda Casado, Isabel Camino, María Santos Martínez, Bilal Zulfiqar, Vicky Marie Avery, Pim-Bart Feijens, Natascha Van Pelt, An Matheeussen, Sarah Hendrickx, Louis Maes, Guy Caljon, Vanessa Yardley, Susan Wyllie, Susan A Charman, Eric Chatelain
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc 1 . Science translational medicine 15 (726) (2023)
Silvia González, Richard J Wall, John Thomas, Stéphanie Braillard, Gino Brunori, Isabel Camino, Juan Cantizani, Sandra Carvalho, Pablo Castañeda Casado, Eric Chatelain, Ignacio Cotillo, Jose M Fiandor, Amanda Fortes Francisco, David Grimsditch, Martine Keenan, John M Kelly, Albane Kessler, Chiara Luise, Jonathan J Lyon, Lorna M MacLean, Maria Marco, J Julio Martin, María Santos Martínez, Christy Paterson, Kevin D Read, Angel Santos-Villarejo, Fabio Zuccotto, Susan Wyllie, Timothy J Miles, Manu De Rycker
Short-course combination treatment for experimental chronic Chagas disease. Science translational medicine 15 (726) (2023)
Katrien Van Bocxlaer, Kerri-Nicola McArthur, Andy Harris, Mo Alavijeh, Stéphanie Braillard, Charles E Mowbray, Simon L Croft
Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis. Pharmaceutics 13 (4) (2021)